Company Overview of ImmunoBiosciences, Inc.
ImmunoBiosciences, Inc. develops a vaccine platform technology solution to create vaccines to combat diseases. Its technology combines specific antigens (viruses or bacteria) with corresponding neutralizing antibodies in a complex to create vaccines. The company offers its solutions in the areas of respiratory syncytial virus, seasonal/pandemic influenza, and dengue fever. The company was incorporated in 2001 and is based in Raleigh, North Carolina.
920 Main Campus Drive
Raleigh, NC 27606-5213
Founded in 2001
Key Executives for ImmunoBiosciences, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact ImmunoBiosciences, Inc., please visit www.immunobiosciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.